Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Real-World lupus drug study launches in poland

NCT ID NCT06673043

First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 27 times

Summary

This study tracks 100 adults with lupus who are taking anifrolumab as part of their normal treatment in Poland. Researchers will measure changes in disease activity and overall health over time. The goal is to see how well the drug works outside of controlled trials, in real-life settings.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUPUS ERYTHEMATOSUS, SYSTEMIC are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Research Site

    RECRUITING

    Bydgoszcz, Poland

  • Research Site

    RECRUITING

    Bytom, Poland

  • Research Site

    RECRUITING

    Gdansk, Poland

  • Research Site

    RECRUITING

    Katowice, Poland

  • Research Site

    RECRUITING

    Krakow, Poland

  • Research Site

    RECRUITING

    Lodz, Poland

  • Research Site

    RECRUITING

    Lublin, Poland

  • Research Site

    RECRUITING

    Poznan, Poland

  • Research Site

    RECRUITING

    Rzeszów, Poland

  • Research Site

    RECRUITING

    Warsaw, Poland

  • Research Site

    RECRUITING

    Wroclaw, Poland

Conditions

Explore the condition pages connected to this study.